Published on 22 Jul 2023 on Zacks via Yahoo Finance

Why Royalty Pharma (RPRX) Might Surprise This Earnings Season

Investors are always looking for stocks that are poised to beat at earnings season and Royalty Pharma plc RPRX may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Royalty Pharma is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for RPRX in this report.In fact, the Most Accurate Estimate for the current quarter is currently at 84 cents per share for RPRX, compared to a broader Zacks Consensus Estimate of 83 cents per share. This suggests that analysts have very recently bumped up their estimates for RPRX, giving the stock a Zacks Earnings ESP of +0.80% heading into earnings season.

Royalty Pharma PLC Price and EPS Surprise